Bright Minds Biosciences Inc. (DRUG) Financials
DRUG Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 5.2 million | 643992 |
2023-09-30 | 5.1 million | 206656 |
2023-06-30 | 6.4 million | 555076 |
2023-03-31 | 7.4 million | 769096 |
DRUG Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -619811 | 165076 |
2023-09-30 | -881147 | 294688 |
2023-06-30 | -1.2 million | 179433 |
2023-03-31 | -1.1 million | 22141 |
DRUG Net Income
No data available :(
DRUG Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 5.1 million | - | 41137 |
2023-09-30 | 5.0 million | - | 54117 |
2023-06-30 | 6.1 million | - | 69049 |
2023-03-31 | 7.1 million | - | 80065 |
DRUG Shares Outstanding
DRUG Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 923982 | 274875 | 27594 |
2023-09-30 | - | 802998 | 310926 | 26930 |
2023-06-30 | - | 793686 | 259271 | 28025 |
2023-03-31 | - | 1.0 million | 412437 | 3436 |
DRUG Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 13656 |
2023-09-30 | - | 13326 |
2023-06-30 | - | 13682 |
2023-03-31 | - | 13388 |
DRUG
Price: $1.05
52 week price:
Earnings Per Share: -1.21 USD
P/E Ratio: -1.30
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 141500
Market Capitalization: 5.8 million